HeartIO - About the company
HeartIO is a seed company based in Pittsburgh (United States), founded in 2019 by Nick Flanigan and Adam Butchy. It operates as a Provider of AI-based platform for the diagnosis of heart abnormalities. HeartIO has raised $4.45M in funding. The company has 63 active competitors, including 20 funded and 2 that have exited. Its top competitors include companies like HeartFocus, Anumana and CorVista.
Company Details
Heart Input-Output is an AI-based platform for the diagnosis of heart abnormalities. The platform analyses of each beat within a signal to determine the presence of numerous abnormal beats, a comprehensive reading of the 12-lead system to determine the presence of abnormal cardiovascular rhythms, detection of atherosclerotic cardiovascular disease on a per vessel basis.
- Website
- heartio.ai
Key Metrics
Founded Year
2019
Location
Pittsburgh, United States
Stage
Seed
Total Funding
$4.45M in 2 rounds
Latest Funding Round
Investors
Ranked
9th among 63 active competitors
Employee Count
16 as on Aug 31, 2026
Similar Companies
Legal entities associated with HeartIO
HeartIO is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Heart Input Output, Inc. CIN: 825358736 , United States, Active | - | - | - |
Sign up to download HeartIO's company profile
HeartIO's funding and investors
HeartIO has raised a total funding of $4.45M over 2 rounds. Its first funding round was on Nov 14, 2020. Its latest funding round was a Seed round on Mar 16, 2026 for $*****. 4 investors participated in its latest round. HeartIO has 5 institutional investors.
Here is the list of recent funding rounds of HeartIO:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 16, 2026 | 1835733 | Seed | 1115953 | 4116238 | 3981316 | 6566121 |
Nov 14, 2020 | 4241567 | Seed | 5850603 | 6181251 | 4482053 | 2570444 |
View details of HeartIO's funding rounds and investors
HeartIO's founders and board of directors
Founder? Claim ProfileHere are the details of HeartIO's key team members:
- Nick Flanigan: Co-Founder of HeartIO.
- Adam Butchy: Co-Founder of HeartIO. Contact Info: 1 email address
- Utkars Jain: CEO of HeartIO. Contact Info: 1 email address
View details of HeartIO's Founder profiles and Board Members
HeartIO's employee count trend
HeartIO has 16 employees as of Aug 26. Here is HeartIO's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
HeartIO's Competitors and alternates
Top competitors of HeartIO include HeartFocus, Anumana and CorVista. Here is the list of Top 10 competitors of HeartIO, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | HeartFocus 2023, Bordeaux (France), Seed | AI-driven app for healthcare professionals to perform cardiac ultrasound exams | $6M | 62/100 | |
2nd | Anumana 2021, Cambridge (United States), Series C | AI-based ECG detection and cardiology diagnosis solutions | $95.4M | 62/100 | |
3rd | Developer of diagnostic systems for identifying cardiovascular and pulmonary conditions | $89.8M | 60/100 | ||
4th | Powerful Medical 2019, Bratislava (Slovakia), Series A | Developer of AI-powered platform for interpreting electrocardiograms and detecting heart conditions | $11.4M | 59/100 | |
5th | Laza Medical 2022, Los Gatos (United States), Series A | AI-powered robotically-assisted imaging solutions for cardiovascular interventions | $36M | 57/100 | |
6th | Volta Medical 2016, Marseille (France), Series B | AI-based software developer for providing cardiac mapping assistance tools | $74.2M | 56/100 | |
7th | VahatiCor 2021, Santa Clara (United States), Series B | Platform offering solutions on addressing coronary microvascular disease | $23M | 52/100 | |
8th | Cardio Intelligence 2019, Minato City (Japan), Series B | AI-based medical devices for diagnosis and treatment of heart diseases | $3.22M | 47/100 | |
9th | HeartIO 2019, Pittsburgh (United States), Seed | Provider of AI-based platform for the diagnosis of heart abnormalities | $4.45M | 46/100 | |
10th | Analytics4Life 2012, Toronto (Canada), Series C | Developer of diagnostic platform using AI for cardiovascular disease assessments | $69.2M | 46/100 |
Looking for more details on HeartIO's competitors? Click here to see the top ones
HeartIO's Investments and acquisitions
HeartIO has made no investments or acquisitions yet.
Reports related to HeartIO
Here is the latest report on HeartIO's sector:
News related to HeartIO
Media has covered HeartIO for 1 event in last 1 year.
•
HEARTio Secures $4.25M to Advance ECGio AI Platform for Coronary Artery Disease DetectionHIT Consultant•Mar 16, 2026•Intelligence Ventures, Audacious Capital, HeartIO, VU Venture Partners and 1 other
Are you a Founder ?
FAQs about HeartIO
Explore our recently published companies
- Christoph Hein - Lemwerder based, Unfunded company
- Sandra Godwin - Unfunded company
- KCG - Unfunded company
- Omnipresence Exim - Hyderabad based, 2019 founded, Unfunded company
- ValaCare - Toronto based, 2026 founded, Unfunded company
- AI Fairness 360 - Unfunded company
_1578485796747.png?format=webp&height=120&width=120)